Form 4: Surmodics CFO Sells 7,009 Shares in Open Market Transaction

Surmodics' Chief Financial Officer, Timothy J. Arens, sold 7,009 shares of common stock on November 26, 2024, at an average price of $39.4426 per share.

Summary

• Timothy J. Arens, the Chief Financial Officer of Surmodics Inc., sold 7,009 shares of the company's common stock on November 26, 2024.
• The sale was executed in multiple transactions with prices ranging from $39.40 to $39.585 per share.
• The weighted average price for the sale was $39.4426 per share.
• Following the transaction, Mr. Arens directly owns 70,350 shares of Surmodics common stock.

Sentiment

Score: 5

Explanation: The document is neutral, reporting a standard insider transaction. There is no indication of positive or negative sentiment.

Industry Context

This is a routine Form 4 filing, which is a standard disclosure for insider transactions. It does not indicate any specific trend in the medical device industry.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies, and this transaction is consistent with typical insider trading activity.
• There are no specific industry benchmarks to compare this transaction to, as it is an individual sale by an executive.

Stakeholder Impact

• The sale of shares by the CFO may have a minor impact on shareholder sentiment, but it is not expected to significantly affect the company's operations or financial position.

Key Dates

Keywords

Surmodics, SRDX, insider trading, stock sale, CFO, Timothy J. Arens, Form 4, equity securities